Legend Biotech (LEGN) Total Liabilities (2019 - 2025)

Legend Biotech has reported Total Liabilities for 7 years, with the latest figure at $731.6 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 16.2% year-over-year to $731.6 million; the trailing twelve-month figure through Dec 2025 stood at $731.6 million (up 16.2% YoY), and the FY2025 full-year result was $731.6 million, up 16.2% from the prior year.
• Total Liabilities for Q4 2025 stood at $731.6 million, up from $701.7 million in the prior quarter.
• The five-year high for Total Liabilities was $535.2 billion in Q2 2021, with the low at $353.5 million in Q4 2021.
• Historically, Total Liabilities has averaged $53.0 billion across 5 years, with a median of $606.5 million in 2022.
• Annual changes were most pronounced in 2021 — Total Liabilities surged 184.36% — and 2022, when it plunged 99.85%.
• Legend Biotech's Total Liabilities stood at $353.5 million in 2021, then soared by 65.95% to $586.7 million in 2022, then increased by 1.8% to $597.2 million in 2023, then grew by 5.42% to $629.6 million in 2024, then increased by 16.2% to $731.6 million in 2025.
• The last three Total Liabilities figures came in at $731.6 million (Q4 2025), $701.7 million (Q3 2025), and $654.4 million (Q2 2025), per Business Quant data.